Cargando…
Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever
Familial Mediterranean fever (FMF) is caused by mutations within the Mediterranean fever (MEFV) gene. Disease severity depends on genotype and gene dose with most serious clinical courses observed in patients with M694V homozygosity. Neutrophils are thought to play an important role in the initiatio...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325897/ https://www.ncbi.nlm.nih.gov/pubmed/32655537 http://dx.doi.org/10.3389/fimmu.2020.00716 |
_version_ | 1783552228618928128 |
---|---|
author | Stoler, Iris Freytag, Judith Orak, Banu Unterwalder, Nadine Henning, Stephan Heim, Katrin von Bernuth, Horst Krüger, Renate Winkler, Stefan Eschenhagen, Patience Seipelt, Eva Mall, Marcus A. Foell, Dirk Kessel, Christoph Wittkowski, Helmut Kallinich, Tilmann |
author_facet | Stoler, Iris Freytag, Judith Orak, Banu Unterwalder, Nadine Henning, Stephan Heim, Katrin von Bernuth, Horst Krüger, Renate Winkler, Stefan Eschenhagen, Patience Seipelt, Eva Mall, Marcus A. Foell, Dirk Kessel, Christoph Wittkowski, Helmut Kallinich, Tilmann |
author_sort | Stoler, Iris |
collection | PubMed |
description | Familial Mediterranean fever (FMF) is caused by mutations within the Mediterranean fever (MEFV) gene. Disease severity depends on genotype and gene dose with most serious clinical courses observed in patients with M694V homozygosity. Neutrophils are thought to play an important role in the initiation and perpetuation of inflammatory processes in FMF, but little is known about the specific characteristics of these cells in FMF patients. To further characterize neutrophilic inflammatory responses in FMF and to delineate gene–dose effects on a cellular level, we analyzed cytokine production and activation levels of isolated neutrophils derived from patients and subjects with distinct MEFV genotypes, as well as healthy and disease controls. Serum levels of interleukin-18 (IL-18) (median 11,485 pg/ml), S100A12 (median 9,726 ng/ml), and caspase-1 (median 394 pg/ml) were significantly increased in patients with homozygous M694V mutations. Spontaneous release of S100A12, caspase-1, proteinase 3, and myeloperoxidase (MPO) was restricted to ex vivo cultured neutrophils derived from patients with two pathogenic MEFV mutations. IL-18 secretion was highest in patients with two mutations but also increased in neutrophils from healthy heterozygous MEFV mutation carriers, exhibiting an ex vivo gene–dose effect, which was formerly described by us in patients' serum. CD62L (l-selectin) was spontaneously shed from the surface of ex vivo cultured neutrophils [median of geometric mean fluorescence intensity (gMFI) after 5 h: 28.8% of the initial level]. While neutrophils derived from healthy heterozygous mutation carriers again showed a gene–dose effect (median gMFI: 67.1%), healthy and disease controls had significant lower shedding rates (median gMFI: 83.6 and 82.9%, respectively). Co-culture with colchicine and/or stimulation with adenosine triphosphate (ATP) and lipopolysaccharide (LPS) led to a significant increase in receptor shedding. Neutrophils were not prevented from spontaneous shedding by blocking IL-1 or the NLRP3 inflammasome. In summary, the data demonstrate that ex vivo cultured neutrophils derived from FMF patients display a unique phenotype with spontaneous release of high amounts of IL-18, S100A12, MPO, caspase-1, and proteinase 3 and spontaneous activation as demonstrated by the loss of CD62L. Neutrophilic activation seems to be independent from IL-1 activation and displays a gene–dose effect that may be responsible for genotype-dependent phenotypes. |
format | Online Article Text |
id | pubmed-7325897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73258972020-07-09 Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever Stoler, Iris Freytag, Judith Orak, Banu Unterwalder, Nadine Henning, Stephan Heim, Katrin von Bernuth, Horst Krüger, Renate Winkler, Stefan Eschenhagen, Patience Seipelt, Eva Mall, Marcus A. Foell, Dirk Kessel, Christoph Wittkowski, Helmut Kallinich, Tilmann Front Immunol Immunology Familial Mediterranean fever (FMF) is caused by mutations within the Mediterranean fever (MEFV) gene. Disease severity depends on genotype and gene dose with most serious clinical courses observed in patients with M694V homozygosity. Neutrophils are thought to play an important role in the initiation and perpetuation of inflammatory processes in FMF, but little is known about the specific characteristics of these cells in FMF patients. To further characterize neutrophilic inflammatory responses in FMF and to delineate gene–dose effects on a cellular level, we analyzed cytokine production and activation levels of isolated neutrophils derived from patients and subjects with distinct MEFV genotypes, as well as healthy and disease controls. Serum levels of interleukin-18 (IL-18) (median 11,485 pg/ml), S100A12 (median 9,726 ng/ml), and caspase-1 (median 394 pg/ml) were significantly increased in patients with homozygous M694V mutations. Spontaneous release of S100A12, caspase-1, proteinase 3, and myeloperoxidase (MPO) was restricted to ex vivo cultured neutrophils derived from patients with two pathogenic MEFV mutations. IL-18 secretion was highest in patients with two mutations but also increased in neutrophils from healthy heterozygous MEFV mutation carriers, exhibiting an ex vivo gene–dose effect, which was formerly described by us in patients' serum. CD62L (l-selectin) was spontaneously shed from the surface of ex vivo cultured neutrophils [median of geometric mean fluorescence intensity (gMFI) after 5 h: 28.8% of the initial level]. While neutrophils derived from healthy heterozygous mutation carriers again showed a gene–dose effect (median gMFI: 67.1%), healthy and disease controls had significant lower shedding rates (median gMFI: 83.6 and 82.9%, respectively). Co-culture with colchicine and/or stimulation with adenosine triphosphate (ATP) and lipopolysaccharide (LPS) led to a significant increase in receptor shedding. Neutrophils were not prevented from spontaneous shedding by blocking IL-1 or the NLRP3 inflammasome. In summary, the data demonstrate that ex vivo cultured neutrophils derived from FMF patients display a unique phenotype with spontaneous release of high amounts of IL-18, S100A12, MPO, caspase-1, and proteinase 3 and spontaneous activation as demonstrated by the loss of CD62L. Neutrophilic activation seems to be independent from IL-1 activation and displays a gene–dose effect that may be responsible for genotype-dependent phenotypes. Frontiers Media S.A. 2020-06-11 /pmc/articles/PMC7325897/ /pubmed/32655537 http://dx.doi.org/10.3389/fimmu.2020.00716 Text en Copyright © 2020 Stoler, Freytag, Orak, Unterwalder, Henning, Heim, von Bernuth, Krüger, Winkler, Eschenhagen, Seipelt, Mall, Foell, Kessel, Wittkowski and Kallinich. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Stoler, Iris Freytag, Judith Orak, Banu Unterwalder, Nadine Henning, Stephan Heim, Katrin von Bernuth, Horst Krüger, Renate Winkler, Stefan Eschenhagen, Patience Seipelt, Eva Mall, Marcus A. Foell, Dirk Kessel, Christoph Wittkowski, Helmut Kallinich, Tilmann Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever |
title | Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever |
title_full | Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever |
title_fullStr | Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever |
title_full_unstemmed | Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever |
title_short | Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever |
title_sort | gene–dose effect of mefv gain-of-function mutations determines ex vivo neutrophil activation in familial mediterranean fever |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325897/ https://www.ncbi.nlm.nih.gov/pubmed/32655537 http://dx.doi.org/10.3389/fimmu.2020.00716 |
work_keys_str_mv | AT stoleriris genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT freytagjudith genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT orakbanu genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT unterwaldernadine genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT henningstephan genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT heimkatrin genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT vonbernuthhorst genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT krugerrenate genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT winklerstefan genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT eschenhagenpatience genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT seipelteva genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT mallmarcusa genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT foelldirk genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT kesselchristoph genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT wittkowskihelmut genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever AT kallinichtilmann genedoseeffectofmefvgainoffunctionmutationsdeterminesexvivoneutrophilactivationinfamilialmediterraneanfever |